Clinical Trial Update: VAST - Ventricular Arrhythmia Suppression Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update for VAST (Ventricular Arrhythmia Suppression Trial) completed. The study evaluated management of ventricular tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Tachycardia | Phase 4 | Status: COMPLETED